| Michael Patrick Tomlinson, CRNA | |
|
3719 Dauphin St, Mobile, AL 36608-1753 | |
| (251) 342-3000 | |
| Not Available |
| Full Name | Michael Patrick Tomlinson |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 3719 Dauphin St, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104025014 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1-101218 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Patrick Tomlinson, CRNA Po Box 851417, Mobile, AL 36685-1417 Ph: (251) 342-3000 | Michael Patrick Tomlinson, CRNA 3719 Dauphin St, Mobile, AL 36608-1753 Ph: (251) 342-3000 |
News Archive
Association Of Hospice Agency Profit Status With Patient Diagnosis, Location of Care, and Length of Stay - "The current Medicare Hospice Benefit reimburses hospices at a fixed per diem rate that does not consider the patient's diagnosis, location of care, or hospice LOS [length-of-stay]," and as such, "profit can be maximized by caring for patients with certain diagnoses that require fewer skilled services, patients residing in nursing homes, or patients with longer hospice stays."
Following the momentum of launching an industry-defining open architecture platform, Eclipsys Corporation today announced a partnership with Rothman Healthcare Research to build its Patient Condition Tracker software solution on the Helios by Eclipsys™ platform.
Why do some people comfortably walk between skyscrapers on a high-wire or raft the Niagara Falls in a wooden barrel whereas others freeze on the mere thought of climbing off escalators in a shopping mall? In a new study, scientists have found that a certain type of cells in the hippocampus play a key role.
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
› Verified 6 days ago
Johnathan E Bruns, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-432-4497 Fax: 251-432-0577 | |
Mrs. Lisa M Mckinley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd, Suite 430, Mobile, AL 36608 Phone: 251-631-3270 | |
Ted W Holmes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3719 Dauphin St, Springhill Medical Center Anesthesia Dept, Mobile, AL 36608 Phone: 251-342-3000 Fax: 251-342-3043 | |
Lindsey Lovorn Diehl, DNP Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6801 Airport Blvd, Mobile, AL 36608 Phone: 351-633-1000 | |
Richard Williams, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 205-848-2925 Fax: 334-377-4417 | |
Jennifer D Thomas, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-432-4497 Fax: 251-432-0577 | |
John Adam Self, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2451 Fillingim St, Room 335, Mobile, AL 36617 Phone: 251-471-7045 |